High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP
S. Dhar, M. Chakravarti, N. Ganguly, A. Saha, S. Dasgupta, Saurav Bera, A. Sarkar, Kamalika Roy, J. Das, A. Bhuniya, Sarbari Ghosh, M. Sarkar, Srabanti Hajra, S. Banerjee, Chiranjib Pal, Bhaskar Saha, K. K. Mukherjee, R. Baral, A. Bose
Frontiers in Immunology